The treatment of rejection: A trial of acetylsalicylic acid, dipyridamole, and heparin1

C. R. P. George, Sherrill J. Slichter, Leonard J. Quadracci, Gerald M. Kenny, Melvin B. Dennis, Gary E. Striker, Laurence A. Harker

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Serial studies of platelet and fibrinogen survival were performed in 26 nonimmuno- suppressed dogs after allogenic renal transplant operations. Treatment with acetylsali-cylic acid, dipyridamole, and heparin failed to improve the selective platelet destruction which occurred in untreated animals, and it did not improve postoperative longevity. There was a high incidence of postoperative wound and intrarenai hemorrhage after heparin treatment. These results are consistent with the hypothesis that platelet destruction is a consequence rather than the cause of acute graft rejection, and it is concluded that antithrombotic therapy is not of practical benefit in preventing acute rejection.

Original languageEnglish
Pages (from-to)237-240
Number of pages4
JournalTransplantation
Volume20
Issue number3
DOIs
StatePublished - Sep 1975
Externally publishedYes

Fingerprint

Dive into the research topics of 'The treatment of rejection: A trial of acetylsalicylic acid, dipyridamole, and heparin1'. Together they form a unique fingerprint.

Cite this